Avricore Health (AVCRF) Cash from Investing Activities (2014 - 2026)
Avricore Health (AVCRF) posted quarterly Cash from Investing Activities of -$2075.3 for Q1 2026, up 96.38% year-over-year from -$1056.8 in Q1 2025, and up 62.43% quarter-over-quarter from -$5524.4 in Q4 2025.
Avricore Health (AVCRF) Cash from Investing Activities (2014 - 2026) Analysis & Trends
Avricore Health (AVCRF) has reported Cash from Investing Activities for 10 consecutive years, with -$2075.3 the latest figure, recorded in Q1 2026.
- In Q1 2026, Cash from Investing Activities rose 96.38% year-over-year to -$2075.3; the TTM figure through Mar 2026 stood at -$25217.4 (up 92.87% YoY), while the FY2025 annual figure was -$81851.3, up 45.43% from the prior year.
- Cash from Investing Activities improved to -$2075.3 in Q1 2026 per AVCRF's latest filing, from -$5524.4 in the prior quarter.
- Across five years, Cash from Investing Activities topped out at -$917.37 in Q1 2022 and bottomed at -$467863.2 in Q3 2022.
- Historically, Cash from Investing Activities has averaged -$129385.3 across 5 years, with a median of -$107864.6 in 2022.
- Annual changes were most pronounced in 2023 — Cash from Investing Activities slumped 18285.52% — and 2026, when it jumped 96.38%.
- Avricore Health's Cash from Investing Activities stood at -$323567.3 in 2022, then gained by 18.06% to -$265140.1 in 2023, then soared by 46.47% to -$141918.4 in 2024, then soared by 96.11% to -$5524.4 in 2025, then soared by 62.43% to -$2075.3 in 2026.
- Business Quant data shows AVCRF's Cash from Investing Activities at -$2075.3 in Q1 2026, -$5524.4 in Q4 2025, and -$13413.7 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 234.15 Bn | 230.09 Bn | 8.34 Bn | 164.00 Mn |
| 2 | Danaher | 152.10 Bn | 147.75 Bn | 3.61 Bn | -10.15 Bn |
| 3 | Natera | 48.48 Bn | 47.38 Bn | 486.15 Mn | -63.43 Mn |
| 4 | Agilent Technologies | 44.35 Bn | 42.55 Bn | 990.00 Mn | -77.00 Mn |
| 5 | Iqvia Holdings | 43.68 Bn | 41.60 Bn | 1.44 Bn | -381.00 Mn |
| 6 | Idexx Laboratories | 43.02 Bn | 42.83 Bn | 779.09 Mn | -25.50 Mn |
| 7 | Illumina | 34.39 Bn | 33.22 Bn | 770.00 Mn | -122.00 Mn |
| 8 | Mettler Toledo International | 28.29 Bn | 28.24 Bn | 650.22 Mn | -1.94 Mn |
| 9 | Labcorp Holdings | 27.51 Bn | 27.37 Bn | 1.11 Bn | -366.20 Mn |
| 10 | Avricore Health | 3.04 Mn | 3.01 Mn | -6.20 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -2,075.32 |
| Mar 31, 2026 | -2,075.32 |
| Dec 31, 2025 | -5,524.43 |
| Dec 31, 2025 | -5,524.43 |
| Sep 30, 2025 | -13,413.68 |
| Sep 30, 2025 | -13,413.68 |
| Jun 30, 2025 | -4,203.98 |
| Jun 30, 2025 | -4,203.98 |
| Mar 31, 2025 | -57,407.10 |
| Mar 31, 2025 | -57,407.10 |
| Sep 30, 2024 | -141,460.98 |
| Sep 30, 2024 | -141,460.98 |
| Jun 30, 2024 | -91,157.87 |
| Jun 30, 2024 | -91,157.87 |
| Mar 31, 2024 | -62,477.03 |
| Mar 31, 2024 | -62,477.03 |
| Dec 31, 2023 | -265,140.15 |
| Dec 31, 2023 | -265,140.15 |
| Sep 30, 2023 | -199,467.78 |
| Sep 30, 2023 | -199,467.78 |